메뉴 건너뛰기




Volumn 99, Issue 3, 2013, Pages

Lapatinib and renal impairment: A case report

Author keywords

Hemodialysis; Human epidermal growth factor receptor 2; Lapatinib; Letrozole; Metastatic breast cancer

Indexed keywords

ANASTROZOLE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; GOSERELIN; KI 67 ANTIGEN; LAPATINIB; LETROZOLE; PROGESTERONE RECEPTOR; TAMOXIFEN; TRASTUZUMAB; ANTINEOPLASTIC AGENT; ERBB2 PROTEIN, HUMAN; MONOCLONAL ANTIBODY; NITRILE; QUINAZOLINE DERIVATIVE; TRIAZOLE DERIVATIVE; TUMOR MARKER;

EID: 84885995645     PISSN: 03008916     EISSN: 20382529     Source Type: Journal    
DOI: 10.1177/030089161309900334     Document Type: Article
Times cited : (10)

References (3)
  • 3
    • 77649100030 scopus 로고    scopus 로고
    • Lapatinib plus letrozole as first-line therapy for HER-2+ hormone receptor-positive metastatic breast cancer
    • Schwartzberg LS, Franco SX, Florance A, O'Rourke L, Maltzman J, Johnston S: Lapatinib plus letrozole as first-line therapy for HER-2+ hormone receptor-positive metastatic breast cancer. Oncologist, 15: 122-129, 2000.
    • (2000) Oncologist , vol.15 , pp. 122-129
    • Schwartzberg, L.S.1    Franco, S.X.2    Florance, A.3    O'Rourke, L.4    Maltzman, J.5    Johnston, S.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.